Announcements Trials
Browse Landscape

Phase

Phase 2 34Phase 3 12Phase NA 8Phase 1/2 8Phase 4 6Phase 2/3 5Phase 1 3

Status

Completed 47Terminated 10Unknown 8Withdrawn 2Recruiting 2Suspended 1Active not recruiting 1

Sponsor Class

OTHER 6NIH 2

Study Type

Interventional 8

Sponsor

Cancer Type

Gastrointestinal 4Dermatologic 2Sarcoma 1Breast 1

Conditions

Carcinoma, Hepatocellular 3Melanoma 2Sarcoma 1Liver Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 37Gemcitabine 31Paclitaxel 28Cisplatin 28Carboplatin 27Capecitabine 27camrelizumab 25Nivolumab 24apatinib 23Oxaliplatin 21fludarabine 20Radiotherapy 20toripalimab 19Drug Therapy 18Immunotherapy, Adoptive 17pembrolizumab 16Docetaxel 16Bevacizumab 16Dexamethasone 15N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 14Injections 14tislelizumab 13Temozolomide 13Rituximab 13Cetuximab 13Irinotecan 12Fluorouracil 11130-nm albumin-bound paclitaxel 11anlotinib 10Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Sorafenib × Clear all
NCT04926532 2021-06-15

Toripalimab

Shanghai Zhongshan Hospital

Phase 1/2 Unknown
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03645980 2020-10-22

DKN-01 Inhibition in Advanced Liver Cancer

Johannes Gutenberg University Mainz

Phase 1/2 Unknown
70 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04069949 2019-10-25

STUHCCPVTT

Sichuan University

Phase 1/2 Unknown
39 enrolled
Gastrointestinal

Liver Neoplasms

NCT00538005 2014-01-10

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

National Cancer Institute (NCI)

Phase 1/2 Unknown
54 enrolled
Dermatologic

Melanoma

NCT00811759 2010-10-07

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

National Cancer Institute (NCI)

Phase 1/2 Unknown
58 enrolled
Dermatologic

Melanoma

NCT00999843 2009-10-22

Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer

Fudan University

Phase 1/2 Unknown
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00764972 2008-10-21

Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer

McGill University

Phase 1/2 Unknown
36 enrolled
Breast

Breast Neoplasms

NCT00541840 2008-05-12

Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma

Grupo Espanol de Investigacion en Sarcomas

Phase 1/2 Unknown
24 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡